Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
复制标题

DOI:
10.1002/ijc.29210
复制
发表时间:
2015-03-01
影响因子:
6.4
通讯作者:
Bray, Freddie
Bray, Freddie
中科院分区:
医学1区
文献类型:
--
作者:
Ferlay, Jacques;Soerjomataram, Isabelle;Bray, Freddie

文献摘要

被引文献

相似文献

国际癌症研究机构的GLOBOCAN系列现已提供了2012年全球27种主要癌症和所有癌症的发病率和死亡率估计数。我们回顾了用于编制国家癌症发病率和死亡率估计的来源和方法,并简要描述了癌症地点和世界20个大地区的主要结果。总体而言,2012年有1410万新病例和820万人死亡。最常见的癌症是肺癌(182万)、乳腺癌(167万)和结直肠癌(136万);最常见的癌症死亡原因是肺癌(160万人死亡)、肝癌(74.5万人死亡)和胃癌(72.3万人死亡)。有什么新鲜事吗?在本报告中,我们介绍了世界20个地区主要癌症的最新发病率和死亡率统计数据(2012年)。提供了GLOBOCAN在国家一级编制估计数时使用的数据源和方法的详细信息,并且我们引入了一种新的字母数字评分系统,以提供每个国家估计的稳健性的广泛指示。按癌症地点分列的全球模式概况使人们注意到需要对癌症控制工作进行区域优先排序,以及正在努力改善许多低收入和中等收入国家有限的监测系统。
Estimates of the worldwide incidence and mortality from 27 major cancers and for all cancers combined for 2012 are now available in the GLOBOCAN series of the International Agency for Research on Cancer. We review the sources and methods used in compiling the national cancer incidence and mortality estimates, and briefly describe the key results by cancer site and in 20 large areas of the world. Overall, there were 14.1 million new cases and 8.2 million deaths in 2012. The most commonly diagnosed cancers were lung (1.82 million), breast (1.67 million), and colorectal (1.36 million); the most common causes of cancer death were lung cancer (1.6 million deaths), liver cancer (745,000 deaths), and stomach cancer (723,000 deaths).What's new? In this report, we present the most recent cancer incidence and mortality statistics (for 2012) for the major cancers in 20 regions of the world. Details of the data sources and methods used in GLOBOCAN to compile the estimates at the national level are provided, and we introduce a novel alphanumeric scoring system to give a broad indication of the robustness of the estimation within each country. A global snapshot of the patterns by cancer site brings focus to the need for regional prioritisation of cancer control efforts, as well as the ongoing efforts to improve the limited surveillance systems in many low and middle income countries.